As2O3
Showing 1 - 25 of >10,000
Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)
Recruiting
- Acute Promyelocytic Leukemia
- Realgar-Indigo naturalis formula
- +3 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021
Soccer Training, Body Composition, Physical Activity Trial in Tríkala (FIM-1, FIM-2, FIM-3)
Recruiting
- Soccer Training
- +3 more
- FIM-1
- +3 more
-
Tríkala, GreeceUniversity o Thessaly, School of Physical Education and Sports S
May 30, 2022
Arsenic Trioxide, p53 Mutations, Refractory Cancer Trial in Shanghai (Arsenic Trioxide)
Recruiting
- Arsenic Trioxide
- +3 more
- Arsenic Trioxide
-
Shanghai, ChinaDepartment of Medical Oncology, Shanghai Changzheng Hospital
Jan 4, 2021
Osteosarcoma Trial in Italy (Mifamurtide arm, 3 drugs arm)
Active, not recruiting
- Osteosarcoma
- Mifamurtide arm
- 3 drugs arm
-
Candiolo, Torino, Italy
- +10 more
Sep 16, 2022
Venous Leg Ulcer Trial in Worldwide (Venous Leg Ulcer Standard of Care with Granulox)
Active, not recruiting
- Venous Leg Ulcer
- Venous Leg Ulcer Standard of Care with Granulox
-
Split, Croatia
- +26 more
Jan 16, 2023
Metastatic Pancreatic Cancer Trial in United States (Nab paclitaxel, Gemcitabine, Dociparstat)
Terminated
- Metastatic Pancreatic Cancer
- Nab paclitaxel
- +2 more
-
Scottsdale, Arizona
- +15 more
Jun 2, 2022
Vasomotor Symptoms Associated With Menopause, Hot Flashes Trial in Worldwide (Elinzanetant (BAY3427080), Placebo)
Active, not recruiting
- Vasomotor Symptoms Associated With Menopause
- Hot Flashes
- Elinzanetant (BAY3427080)
- Placebo
-
Birmingham, Alabama
- +98 more
Feb 2, 2023
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Cognitive Frailty Trial in Brescia (Experimental: Oxygen-Ozone (O2-O3), Active Comparator: Oxygen (O2), Placebo Comparator:
Active, not recruiting
- Cognitive Frailty
- Experimental: Oxygen-Ozone (O2-O3)
- +2 more
-
Brescia, ItalyIRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
Oct 10, 2023
Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)
Cataract Trial in Italy, Slovakia, Spain (Chloroprocaine 3%, Tetracaine 0.5%)
Completed
- Cataract
- Chloroprocaine 3%
- Tetracaine 0.5%
-
Bologna, Italy
- +26 more
Apr 19, 2021
Rotator Cuff Tendinopathy Trial in Ankara (Ozone (O2-O3) injection, Corticosteroid injection)
Completed
- Rotator Cuff Tendinopathy
- Ozone (O2-O3) injection
- Corticosteroid injection
-
Ankara, Cankaya, TurkeyMerve Örücü Atar
Jun 13, 2022
Uterine Fibroids Trial in Worldwide (Vilaprisan (BAY1002670))
Completed
- Uterine Fibroids
- Vilaprisan (BAY1002670)
-
Blacktown, New South Wales, Australia
- +139 more
Oct 29, 2021
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Diabetic Foot Ulcer Trial in Germany, Italy, Poland (AUP1602-C, Placebo)
Recruiting
- Diabetic Foot Ulcer
- AUP1602-C
- Placebo
-
Münster, Germany
- +9 more
Oct 30, 2023
Cognitive Impairment, Bipolar Disorder, Depression Trial in Copenhagen (Altitude-like hypoxia (12% O2), Normoxia (20% O2),
Recruiting
- Cognitive Impairment
- +2 more
- Altitude-like hypoxia (12% O2)
- +3 more
-
Copenhagen, Capital Region Of Copenhagen, DenmarkNeurocognition and Emotion in Affective Disorders (NEAD) Centre,
Nov 10, 2023
Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),
Recruiting
- Brain Cancer
- [18F]fluoro-2-deoxy-D-glucose (FDG)
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Jan 3, 2023
NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in
Active, not recruiting
- Non-small Cell Lung Cancer
- Urothelial Cancer
- Avelumab 800 mg in combination with pemetrexed / carboplatin
- +3 more
-
Tucson, Arizona
- +45 more
Oct 13, 2022